Search Results | DrugBank Online

Did you mean urea c 10 and catus acid?

Displaying drugs 15001 - 15025 of 15881 in total

GIVI-MPC

GIVI-MPC is a therapy that uses human-induced pluripotent stem cell-derived myogenic progenitor cells.

Investigational

ATI-355

ATI-355 is a humanized anti-Nogo-A antibody developed by Novartis.

Investigational

OPC1

OPC1 is an oligodendrocyte progenitor cell therapy being investigated for the treatment of acute spinal cord injury.

Investigational

NSI-566 is a stem cell therapy consisting of human spinal cord-derived neural stem cells. Developed by Seneca Biopharma, it is being investigated for the treatment of amyotrophic lateral sclerosis (ALS), stroke, and chronic spinal cord injury (cSCI).

Investigational

Matched Description: … Biopharma, it is being investigated for the treatment of amyotrophic lateral sclerosis (ALS), stroke, and …

Tonabacase

Investigational

Tabituximab barzuxetan yttrium Y-90

A version of tabituximab barzuxetan radiolabeled with yttrium-90.

Investigational

Yttrium Y-90 Labetuzumab

Investigational

BHT-3034

BHT-3034 is a DNA plasmid vaccine immunotherapy under investigation for the treatment of myasthenia gravis.

Investigational

PBKR03

PBKR03 is a non-replicating recombinant adeno-associated virus serotype hu68 vector, containing a transgene encoding the human galactosylceramidase (GALC) enzyme.

Investigational